Disease/Infection News

RSS

Healthpoint to launch ULTRACEPT Antiseptic Handwash

A new antiseptic handwash, based on a formula previously used only by surgeons and other clinicians, will soon be available to consumers and provides up to six hours of prolonged germ kill with repeated use.

11 Nov 2009

New visitation guidelines to prevent novel flu spread

The New Jersey Hospital Association has issued new visitation guidelines for the state's hospitals to help them protect patients, staff and visitors from H1N1 influenza.

11 Nov 2009

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Academic Health Center scientists, physicians, and research centers have attracted 128 grants totaling nearly $35 million in federal stimulus money (as of Nov. 10) since the American Recovery and Reinvestment Act was approved in February 2009. This will result in a total economic impact of more than $105 million; according to the National Institutes of Health, $1 of research funding multiplies to more than $2 of goods and services in the economy.

11 Nov 2009

Also in Global Health: Child sexual abuse in Zimbabwe; dengue outbreak in Cape Verde; program reduces waste in Kenya slums

The Mail & Guardian examines how the "economic collapse" in Zimbabwe has contributed to rising numbers of children falling victims to sexual abuse. "A single clinic in the capital, Harare, says it has treated nearly 30,000 girls and boys who were abused in the past four years - an average of 20 per day." The article examines other contributing factors to the sexual abuse of children in Zimbabwe and a recent program that aims to make schools safe places for Zimbabwe's children (11/10).

11 Nov 2009

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

In follow-up coverage to the WHO's report on women's health, several news outlets examine the impact HIV/AIDS is having on women around the world. "In its first study of women's health, the World Health Organization said yesterday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44," the Associated Press/Boston Globe reports (11/10).

11 Nov 2009

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.

10 Nov 2009

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.

10 Nov 2009

Researcers identify a new array of genes in GAS

Group A streptococcus (GAS) is a human pathogenic bacteria. Many people carry GAS asymptomatically in their upper respiratory tract and other anatomic sites. However, these bacteria can cause a variety of human diseases ranging from superficial skin and throat infections to highly invasive life-threatening diseases such as toxic shock and necrotizing fasciitis, commonly known as the flesh-eating bacteria.

10 Nov 2009

Speaker Pelosi praises H.R. 3962 that will improve Medicaid access to HIV/AIDS-affected people

"Effective drug treatments have improved both health and quality of life for thousands of Americans living with HIV/AIDS. However, many uninsured, low-income HIV-positive individuals still do not have access to these life-saving medications because they generally do not meet Medicaid requirements until becoming disabled by full-blown AIDS.

10 Nov 2009

New N95 respirator from Safe Life

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today the availability of the Safe Life A400 Series N95 Respirator with Antimicrobial Protection.

10 Nov 2009

Human movement is a key factor for dengue spread in Brazil

Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.

10 Nov 2009

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.

10 Nov 2009

Kenya to launch MSM survey to help control spread of HIV

TIME examines the Kenyan government's upcoming survey of gay men and other men who have sex with men (MSM) in the country's "three biggest cities" in an effort to fight the spread of HIV/AIDS.

10 Nov 2009

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

The WHO on Friday reported on a rising number of H1N1 (swine flu) cases in China and Japan, Reuters/Washington Post reports. "In China, after an earlier wave of mixed influenza activity (seasonal H3N2 and pandemic H1N1), pandemic H1N1 influenza activity now predominates and is increasing," the agency said. "Sharp increases in pandemic flu infections continue to be reported throughout Japan, particularly on the northern island," the news service writes (Nebehay, 11/6).

10 Nov 2009

VOA News examines conculsion of MIM Pan-African Malaria Conference

The 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference ended Friday in Nairobi, Kenya, " with scientists expressing optimism about several developments in the works to prevent, treat, and possibly eradicate a disease that kills nearly one million people in Africa each year," VOA News reports.

10 Nov 2009

NanoViricides to present data on its in vivo studies against influenza

NanoViricides, Inc., announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment.

9 Nov 2009

Concert Pharmaceuticals commences Phase 1b clinical study of its CTP-518 HIV protease inhibitor

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of this multiple ascending dose arm of the Phase 1 study, Concert will receive a $12 million milestone payment under the company’s strategic alliance with GlaxoSmithKline.

9 Nov 2009

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

Researchers are unveiling new data on investigational findings in nearly 450 abstracts on the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Miami Beach, Fla., Nov. 5-10.

9 Nov 2009

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.

7 Nov 2009

Disease/Infection News

Healthpoint to launch ULTRACEPT Antiseptic Handwash

New visitation guidelines to prevent novel flu spread

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Also in Global Health: Child sexual abuse in Zimbabwe; dengue outbreak in Cape Verde; program reduces waste in Kenya slums

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

Study: Patients with difficult to treat hepatitis C are half as likely to initiate treatment

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

Researcers identify a new array of genes in GAS

Speaker Pelosi praises H.R. 3962 that will improve Medicaid access to HIV/AIDS-affected people

New N95 respirator from Safe Life

Human movement is a key factor for dengue spread in Brazil

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

Kenya to launch MSM survey to help control spread of HIV

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

VOA News examines conculsion of MIM Pan-African Malaria Conference

NanoViricides to present data on its in vivo studies against influenza

Concert Pharmaceuticals commences Phase 1b clinical study of its CTP-518 HIV protease inhibitor

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News